PKBO
Price:
$0.07
Market Cap:
$1.62M
Peak Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics addressing unmet needs in the areas of oncology and inflammation. The company's proprietary toxin, PH-1 or Thailanstatin, a spliceosome modulator is being used to generate its first pipeline of novel ADC product candidates to address unmet needs in cancer patients. Its lead product candidate, PHP-303, is a small molecule awaiting Phase II dose clinical study in the orphan disease Alpha1 anti-trypsin deficiency (AATD). The company is based in Palo Alto, California.[Read more]
Industry
Biotechnology
IPO Date
2021-03-15
Stock Exchange
NASDAQ
Ticker
PKBO
According to Peak Bio, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.39. This represents a change of -397.00% compared to the average of 0.13 of the last 4 quarters.
The mean historical PE Ratio of Peak Bio, Inc. over the last ten years is -11735.15. The current -0.39 PE Ratio has changed -99.67% with respect to the historical average. Over the past ten years (40 quarters), PKBO's PE Ratio was at its highest in in the September 2021 quarter at 346.10. The PE Ratio was at its lowest in in the September 2022 quarter at -292.65.
Average
-11735.15
Median
-4398.92
Minimum
-27793.60
Maximum
-5.67
Discovering the peaks and valleys of Peak Bio, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 77.48%
Maximum Annual PE Ratio = -5.67
Minimum Annual Increase = -99.92%
Minimum Annual PE Ratio = -27793.60
Year | PE Ratio | Change |
---|---|---|
2023 | -4398.92 | 77.48% |
2022 | -5.67 | -71.87% |
2021 | -20.16 | -99.92% |
2020 | -26457.40 | -4.81% |
The current PE Ratio of Peak Bio, Inc. (PKBO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-1474.92
5-year avg
-11735.15
10-year avg
-11735.15
Peak Bio, Inc.’s PE Ratio is less than Innovation1 Biotech Inc. (0), less than Adynxx, Inc. (0), less than Ascletis Pharma Inc. (-0.00), less than AVAX Technologies, Inc. (0), greater than Molecular Partners AG (-57.72), less than MediciNova, Inc. (-0.00), greater than Anebulo Pharmaceuticals, Inc. (-3.01), greater than Champions Oncology, Inc. (-10.09), greater than Cyteir Therapeutics, Inc. (-5.95), greater than null (-16.97), greater than null (-3.52),
Company | PE Ratio | Market cap |
---|---|---|
0 | $22.47K | |
0 | $581.00 | |
-0.00 | $154.30M | |
0 | $6.89K | |
-57.72 | $247.30M | |
-0.00 | $82.40M | |
-3.01 | $49.01M | |
-10.09 | $57.64M | |
-5.95 | $108.71M | |
-16.97 | $0 | |
-3.52 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Peak Bio, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Peak Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Peak Bio, Inc.'s PE Ratio?
How is the PE Ratio calculated for Peak Bio, Inc. (PKBO)?
What is the highest PE Ratio for Peak Bio, Inc. (PKBO)?
What is the 3-year average PE Ratio for Peak Bio, Inc. (PKBO)?
What is the 5-year average PE Ratio for Peak Bio, Inc. (PKBO)?
How does the current PE Ratio for Peak Bio, Inc. (PKBO) compare to its historical average?